Article Versions Notes

Eljilany I, Saghand PG, Chen J, Ratan A, McCarter M, Carpten J, Colman H, Ikeguchi AP, Puzanov I, Arnold S, et al. The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors. Cancers. 2023; 15(20):4913. https://doi.org/10.3390/cancers15204913

Eljilany, Islam, Payman Ghasemi Saghand, James Chen, Aakrosh Ratan, Martin McCarter, John Carpten, Howard Colman, Alexandra P. Ikeguchi, Igor Puzanov, Susanne Arnold, and et al. 2023. "The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors" Cancers 15, no. 20: 4913. https://doi.org/10.3390/cancers15204913

Eljilany, I., Saghand, P. G., Chen, J., Ratan, A., McCarter, M., Carpten, J., Colman, H., Ikeguchi, A. P., Puzanov, I., Arnold, S., Churchman, M., Hwu, P., Conejo-Garcia, J., Dalton, W. S., Weiner, G. J., El Naqa, I. M., & Tarhini, A. A. (2023). The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors. Cancers, 15(20), 4913. https://doi.org/10.3390/cancers15204913